Literature DB >> 31261141

Spatial signature of dose patterns associated with acute radiation-induced lung damage in lung cancer patients treated with stereotactic body radiation therapy.

Giuseppe Palma1, Serena Monti, Maria Thor, Andreas Rimner, Joseph O Deasy, Laura Cella.   

Abstract

Thoracic radiation therapy (RT) is often associated with lung side effects, whose etiology is still controversial. Our aim was to explore correlations between local dose in the thoracic anatomy and the radiation-induced lung damage (RILD). To this end, we designed a robust scheme for voxel-based analysis (VBA) to explore dose patterns associated with RILD in non-small-cell lung cancer (NSCLC) patients receiving stereotactic body RT (SBRT). We analyzed 106 NSCLC SBRT patients (median prescription dose: 50 Gy; range: [40-54] Gy) in 4 fractions (range: [3-5]) with clinical and dosimetric records suitable for the analysis. The incidence of acute G1 RILD (RTOG grade  ⩾  1) was 68%. Each planning CT and dose map was spatially normalized to a common anatomical reference using a B-spline inter-patient registration algorithm after masking the gross tumor volume. The tumor-subtracted dose maps were converted into biologically effective dose maps (α/β  =  3 Gy). VBA was performed according to a non-parametric permutation test accounting for multiple comparison, based on a cluster analysis method. The underlying general linear model of RILD was designed to include dose maps and each non-dosimetric variable significantly correlated with RILD. The clusters of voxels with dose differences significantly correlated with RILD at a given p -level (S p ) were generated. The only non-dosimetric variable significantly correlated with RILD was the chronic obstructive pulmonary disease (p   =  0.034). Patients with G1 RILD received significantly (p   ⩽  0.05) higher doses in two voxel clusters S 0.05 in the lower-left lung (14 cm3) and in an area (64 cm3) largely included within the ventricles. The applied VBA represents a powerful tool to probe the dose susceptibility of inhomogeneous organs in clinical radiobiology studies. The identified subregions with dose differences associated with G1 RILD in both the heart and lower lungs endorse a trend of previously reported hypotheses on lung toxicity radiobiology.

Entities:  

Mesh:

Year:  2019        PMID: 31261141     DOI: 10.1088/1361-6560/ab2e16

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  8 in total

1.  Lymphocyte dynamics during and after chemo-radiation correlate to dose and outcome in stage III NSCLC patients undergoing maintenance immunotherapy.

Authors:  Yeona Cho; Yejin Kim; Ibrahim Chamseddine; Won Hee Lee; Hye Ryun Kim; Ik Jae Lee; Min Hee Hong; Byung Chul Cho; Chang Geol Lee; Seungryong Cho; Jin Sung Kim; Hong In Yoon; Clemens Grassberger
Journal:  Radiother Oncol       Date:  2022-01-13       Impact factor: 6.901

2.  Probing thoracic dose patterns associated to pericardial effusion and mortality in patients treated with photons and protons for locally advanced non-small-cell lung cancer.

Authors:  Laura Cella; Serena Monti; Ting Xu; Raffaele Liuzzi; Arnaldo Stanzione; Marco Durante; Radhe Mohan; Zhongxing Liao; Giuseppe Palma
Journal:  Radiother Oncol       Date:  2021-05-09       Impact factor: 6.901

3.  Radiation-Induced Esophagitis in Non-Small-Cell Lung Cancer Patients: Voxel-Based Analysis and NTCP Modeling.

Authors:  Serena Monti; Ting Xu; Radhe Mohan; Zhongxing Liao; Giuseppe Palma; Laura Cella
Journal:  Cancers (Basel)       Date:  2022-04-05       Impact factor: 6.639

4.  Anatomy-based prediction method for determining ipsilateral lung doses in postoperative breast radiation therapy assisted by diagnostic computed tomography images.

Authors:  Zhe Chen; Kengo Kuriyama; Eiji Nakatani; Yoko Sato; Ryo Saito; Kan Marino; Takafumi Komiyama; Hiroshi Onishi
Journal:  Rep Pract Oncol Radiother       Date:  2022-09-19

5.  Risk factors for radiation-induced lung injury in patients with advanced non-small cell lung cancer: implication for treatment strategies.

Authors:  Sha Sha; Jigang Dong; Maoyu Wang; Ziyu Chen; Peng Gao
Journal:  World J Surg Oncol       Date:  2021-07-16       Impact factor: 2.754

6.  Long term results of single high dose Stereotactic Body Radiotherapy in the treatment of primary lung tumors.

Authors:  Luca Nicosia; Chiara Reverberi; Linda Agolli; Luca Marinelli; Vitaliana De Sanctis; Maurizio Valeriani; Mattia F Osti
Journal:  Sci Rep       Date:  2019-10-29       Impact factor: 4.379

7.  Radiation Pneumonitis in Thoracic Cancer Patients: Multi-Center Voxel-Based Analysis.

Authors:  Giuseppe Palma; Serena Monti; Roberto Pacelli; Zhongxing Liao; Joseph O Deasy; Radhe Mohan; Laura Cella
Journal:  Cancers (Basel)       Date:  2021-07-15       Impact factor: 6.639

8.  Radiation-Induced Dyspnea in Lung Cancer Patients Treated with Stereotactic Body Radiation Therapy.

Authors:  Laura Cella; Serena Monti; Maria Thor; Andreas Rimner; Joseph O Deasy; Giuseppe Palma
Journal:  Cancers (Basel)       Date:  2021-07-25       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.